Classes
- Unclear diagnosis in pediatrics and role of modern methods in the differential diagnosisD01000110 | Second Faculty of Medicine
- Methods of molecular genetics and essentials of scientific work +1D0100013 | Second Faculty of Medicine
- Unclear diagnosis in pediatrics ???D01000139 | Second Faculty of Medicine
- An introduction to R and data analysisD01000200 | Second Faculty of Medicine
- data analysis ?????D01000221 | Second Faculty of Medicine
- Modern diagnostics in onco-haematology +2D0100049 | Second Faculty of Medicine
- Selected chapters from oncologyD0100098 | Second Faculty of Medicine
- Selected chapters from paediatric oncologyD0110260 | Second Faculty of Medicine
- Clinical 10 days - Department of Paediatric Haematology and Oncology +1D0110KDHO | Second Faculty of Medicine
- Specialised Nursing in OncologyD0405004 | Second Faculty of Medicine
Publications
- Stem cell transplantation in children with myelodysplastic syndrome in the Czech Republic 1997-20022003 | Second Faculty of Medicine
- Transplanxation of Highly Purified Peripheral CD34+ Stem Cells from Haploidenxical Related Donors for Therapy of Children with Nonmalignant Diseases2002 | Second Faculty of Medicine, Central Library of Charles University
- Relapsing graft rejection in juvenile form of malignant osteopetrosis following haploidentical transplantationPublication without faculty affiliation
- Spontaneous remission and loss of monosomy 7: a window of opportunity for young children with SAMD9L syndrome2024 | Second Faculty of Medicine
- Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias2024 | Second Faculty of Medicine
- Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup2024 | Second Faculty of Medicine
- Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study2024 | Second Faculty of Medicine
- Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study2024 | Second Faculty of Medicine
- NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on MRD-based protocol2023 | Second Faculty of Medicine
- Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/KMT2A Rearrangements in a Modern Therapy Era: A Retrospective International Study2023 | Second Faculty of Medicine
Loading network view...